Pharmena S.A.

zł 2.80As of Sun 8 Nov 2026, 12:00 UTC
WSE:PHRHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR (15.42%)
Div yield —
ROE (31.51%)
Biotechnology
Beta (5Y) 0.47
PE TTM —
TSR TTM (16.42%)
Mkt cap zł 31.19M
ROIC (38.93%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 2.85
1.84%
(39.61%)
Hold 6|12|12|10|10
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.04
0.04
0.04
0.04
23.54%
28.76%
25.34%
11.61%
Revenuezł M
2.817
2.868
3.031
3.003
0.30%
(3.26%)
4.52%
5.24%
Peers (US$7.876M)
Cap (US$)
PE
15.80M
—
14.53M
112.3x
Capital
TTM
5Y
10Y
Leveragex
2.718
0.177
0.159
EBIT/Intx
0.800
0.212
0.210
Own earn%
(4.04)
(44.65)
(38.40)
Sh yield%
20.63
35.99
35.82
Owners
Insiders/Inst%
6.47
27.88
Short interest%
3.19
SBC / revenue%
2.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
24–32
$1 testx
−0.2
Incr. ROIC%
12